U.S. futures turned lower—S&P 500 and Nasdaq 100 futures off roughly 0.3% and 0.5%—after Oracle’s after‑hours results reignited fears over AI spending when it missed cloud sales and announced an additional $15 billion of data‑center investment, sending its shares down more than 10% and knocking the market off a post‑Fed rally. The rapid sentiment reversal, which temporarily pushed Nasdaq futures sharply lower and shaved Treasury yields, underscores renewed concerns about tech valuations, debt and whether hefty AI outlays will pay off, leaving markets vulnerable ahead of weekly jobless claims, delayed wholesale inventories/trade data and heavyweight earnings from Broadcom, Costco and Lululemon. Separately, Gemini Space jumped on CFTC approval to offer prediction‑market derivatives—signaling expansion of crypto‑native trading models—while Novo Nordisk has plunged over 50% year‑to‑date after clinical setbacks, profit warnings and intensifying competition, raising doubts about future growth as semaglutide patents approach expiry.
S&P 500 futures fell about 0.3% and Nasdaq 100 futures about 0.5% as markets pared earlier gains, while Dow futures were little changed; the reversal followed Oracle's after‑hours miss on cloud sales and a $15 billion increase in data‑center spending that sent ORCL shares down more than 10% and extinguished a post‑Fed risk rally. The Oracle shock reintroduced acute concerns about AI capital intensity, tech valuations and corporate debt burdens, triggering intraday Nasdaq futures moves as large as a 1.6% slump and a brief three‑basis‑point drop in 10‑year Treasury yields. The timing raises near‑term event risk: the market is vulnerable ahead of weekly jobless claims and delayed wholesale inventories and trade readings, while heavyweight earnings from Broadcom, Costco and Lululemon could amplify sector dispersion and volatility. Sentiment metrics are moderately negative, and the episode underscores that hopes for a year‑end rally are conditional on clean earnings and a cooling of AI investment fears. Separately, Gemini Space (GEMI) gained CFTC approval to operate a derivatives/prediction markets platform, lifting the stock over 15% premarket and signaling growth opportunities for crypto‑native trading models amid regulatory shifts. Novo Nordisk shares have plunged over 50% YTD following clinical setbacks, profit warnings and intensifying competition, highlighting idiosyncratic downside risk in healthcare tied to pipeline and patent timelines.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
